] . 2015. “Safety And Immunogenicity Of Dna Vaccines Encoding Ebolavirus And Marburgvirus Wild-Type Glycoproteins In A Phase I Clinical Trial.”. J Infect Dis 211 (4). J Infect Dis: 549-57. doi:10.1093/infdis/jiu511.
. 2014. “Homologous Boosting With Adenoviral Serotype 5 Hiv Vaccine (Rad5) Vector Can Boost Antibody Responses Despite Preexisting Vector-Specific Immunity In A Randomized Phase I Clinical Trial.”. Plos One 9 (9). Plos One: e106240. doi:10.1371/journal.pone.0106240.
. 2014. “Safety And Tolerability Of Chikungunya Virus-Like Particle Vaccine In Healthy Adults: A Phase 1 Dose-Escalation Trial.”. Lancet 384 (9959). Lancet: 2046-52. doi:10.1016/S0140-6736(14)61185-5.
. 2013. “Protection Against Malaria By Intravenous Immunization With A Nonreplicating Sporozoite Vaccine.”. Science 341 (6152). Science: 1359-65. doi:10.1126/science.1241800.